MDxHealth Reports Half Year 2019 Financial Results and Strategic Update
Conference call with Q&A today at 11:00 CEST / 10:00 BST, details provided below
IRVINE, CA, and HERSTAL, BELGIUM August 29, 2019 MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced its financial results for the half year ended June 30, 2019, and an update on its corporate strategy, vision and outlook.
Strategic Review Update
Michael McGarrity appointed as Chief Executive Officer in February 2019.